|
The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- Pulsar Helium Inc - White Rock, Canada-based resource company targeting helium in the US and Greenland - Says two US federal government laboratories independently confirm the presence and concentration of helium-3 at its Topaz project in Minnesota. The company says the US Geological Survey and Lawrence Livermore National Laboratory verify helium-3 concentrations of about 11.2 to 11.9 parts per billion from the Jetstream #1 well, consistent with earlier results from the Woods Hole Oceanographic Institution. Pulsar says the findings rank among the highest naturally occurring helium-3 levels reported in a terrestrial reservoir and provide strong third-party validation of the project’s strategic significance. ---------- Aquila European Renewables PLC - currently in a managed wind-down, had previously invested in European renewable energy assets - Confirms the cancellation of its ordinary shares listing on Euronext Growth Dublin, effective Friday, as announced on Thursday. The company says the delisting does not affect its listing on the Official List of the Financial Conduct Authority or trading on the Main Market of the London Stock Exchange. ---------- Amigo Holdings PLC - West and Central Africa-focused gold exploration company - Says it is working with Dubai-based AK Corporation in line with its strategy to focus on gold and rare earth opportunities in Africa. The company says AK has begun early-stage work in Tanzania’s Mara Region, part of the Lake Victoria goldfields, using satellite hyperspectral imaging and micro-seismic surveys to identify potential gold-bearing structures. Amigo says no specific investment has yet been agreed or made and it will update investors as exploration progresses. ---------- Hercules PLC - Cirencester, England-based labour supply company for the UK infrastructure and construction sectors - Says it has been added to Balfour Beatty PLC’s Power Transmission & Distribution preferred supplier list, strengthening its relationship with the infrastructure group. Hercules says it will provide specialist substation, cable and civils labour support, building on its expansion in the power and energy sector following the 2025 acquisitions of Advantage NRG and a majority stake in Lyons Power Services. ---------- BSF Enterprise PLC - London-based biotech company is the owner of companies including 3D Bio-Tissues, a pioneer of lab-grown tissues, as well as the corneal replacement company Kerato - Says its wholly owned unit Kerato secures Quebec government grant funding worth C$663,000, around $478,193 to support veterinary trials and accelerate North American commercialisation of its LiQD Cornea product. Kerato says it will co-fund around 55% of the 18-month programme, with the grant supporting safety and biocompatibility testing, veterinary clinical trials at the University of Montreal, and regulatory and manufacturing preparation. The company says the work aims to de-risk future human trials while advancing the veterinary pathway. Kerato targets the start of animal trials in early 2026 and aims for an initial Canadian launch of LiQD Cornea Animal Health in the first quarter of financial 2027, with first revenues expected thereafter. ---------- Thor Energy PLC - exploration company, which has prospective projects in Australia and the US - Says it has received an A$2.3 million, around $1.5 million cash completion payment from Tivan Ltd following satisfaction of conditions for the sale of the Molyhil tungsten, molybdenum and copper project in Australia’s Northern Territory. Thor says the payment relates to its 75% interest in the FRAM joint venture, with the remaining 25% held by Investigator Resources Ltd. The company adds that three further deferred payments, totalling A$3.9 million, are due between September 2026 and September 2028, payable in cash, shares, or a combination at Tivan’s election. Total sale proceeds to Thor from the Molyhil transaction are expected to amount to A$6.6 million. ---------- Ajax Resources PLC - London-based natural resources investment company focused on South America - Agrees new terms for the conditional acquisition of the Paguanta Project in Chile, replacing and terminating the previously announced deal. Ajax says the newly negotiated agreement follows completion of due diligence and changes to the underlying mineral tenure at Paguanta, which is located in Chile’s Tarapaca region and majority-owned by Asara Resources Ltd. Under the revised terms, Ajax agrees to pay initial consideration of $50,000 in cash and $350,000 in shares, issued at 25 pence each, with no net smelter royalty retained by the vendor. Deferred consideration remains unchanged and comprises up to $1.0 million in cash, payable on the definition of qualifying zinc or copper reserves. ---------- SuperSeed Capital Ltd - Guernsey-based venture capital fund with a portfolio of early-stage technology investments - Announces a related party transaction involving its investment manager. The fund says it will issue a further 90,000 convertible loan notes to SuperSeed Ventures LLP for total proceeds of £90,000 on January 26, extending the existing £1.0 million loan facility first announced in June 2024. SuperSeed notes that the investment manager is a related party under Aquis Stock Exchange rules, adding that the independent directors consider the transaction to be fair and reasonable for shareholders. ---------- Frontier IP Group PLC - invests for income and growth in solar and battery storage assets - Reports strong portfolio progress after a vaccine developed by investee company Vaccine Group outperforms a leading commercial product in pig challenge trials. The group says the vaccine candidate targeting Streptococcus suis delivers superior protection in trials conducted by Moredun Scientific Ltd, validating TVG’s bovine herpesvirus delivery platform beyond cattle and demonstrating efficacy against both bacterial and viral diseases. Frontier IP adds that the results follow previously announced success of TVG’s bovine respiratory syncytial virus vaccine candidates and support ongoing discussions with major animal health companies on commercial development. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
